Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Follicular | 11 | 2023 | 435 | 3.150 |
Why?
|
Thymoma | 3 | 2023 | 186 | 1.330 |
Why?
|
Thymus Neoplasms | 3 | 2023 | 268 | 1.240 |
Why?
|
Lymphoma, B-Cell | 4 | 2022 | 931 | 0.870 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2020 | 76 | 0.720 |
Why?
|
Translocation, Genetic | 3 | 2023 | 1420 | 0.700 |
Why?
|
Splenomegaly | 1 | 2020 | 190 | 0.700 |
Why?
|
Lymphoma, T-Cell | 5 | 2019 | 299 | 0.610 |
Why?
|
Parotid Gland | 1 | 2018 | 168 | 0.590 |
Why?
|
Burkitt Lymphoma | 1 | 2018 | 327 | 0.530 |
Why?
|
Syphilis | 1 | 2018 | 227 | 0.520 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2016 | 180 | 0.510 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2021 | 1378 | 0.470 |
Why?
|
Lymphoma | 4 | 2022 | 1877 | 0.460 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2017 | 340 | 0.460 |
Why?
|
Gene Rearrangement | 3 | 2020 | 1179 | 0.420 |
Why?
|
Skin Neoplasms | 6 | 2022 | 5686 | 0.410 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2021 | 1434 | 0.410 |
Why?
|
Infectious Mononucleosis | 1 | 2012 | 131 | 0.410 |
Why?
|
Mutation | 11 | 2023 | 29786 | 0.400 |
Why?
|
Myasthenia Gravis | 1 | 2013 | 199 | 0.380 |
Why?
|
Myositis | 1 | 2013 | 251 | 0.370 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 2 | 2021 | 30 | 0.350 |
Why?
|
Immunophenotyping | 3 | 2023 | 1880 | 0.330 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1526 | 0.330 |
Why?
|
Scapula | 1 | 2010 | 164 | 0.330 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2021 | 207 | 0.330 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2010 | 171 | 0.320 |
Why?
|
Endometrial Neoplasms | 1 | 2016 | 1353 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2021 | 193 | 0.290 |
Why?
|
Diagnosis, Differential | 7 | 2020 | 12959 | 0.280 |
Why?
|
Bone Diseases | 1 | 2010 | 416 | 0.280 |
Why?
|
Sarcoma, Myeloid | 2 | 2018 | 59 | 0.260 |
Why?
|
Lymph Nodes | 3 | 2020 | 3474 | 0.260 |
Why?
|
Biopsy | 5 | 2018 | 6756 | 0.240 |
Why?
|
Erythrocytes, Abnormal | 1 | 2023 | 125 | 0.220 |
Why?
|
Edema | 3 | 2017 | 789 | 0.220 |
Why?
|
Canaries | 1 | 2002 | 6 | 0.220 |
Why?
|
Leg | 2 | 2018 | 1116 | 0.210 |
Why?
|
Cell Nucleus | 2 | 2023 | 2969 | 0.210 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2018 | 604 | 0.200 |
Why?
|
Neoplasm Proteins | 4 | 2018 | 3703 | 0.200 |
Why?
|
Myeloproliferative Disorders | 2 | 2021 | 606 | 0.200 |
Why?
|
Dendritic Cells | 3 | 2021 | 2725 | 0.190 |
Why?
|
Oncogenes | 2 | 2023 | 1265 | 0.180 |
Why?
|
HIV-1 | 1 | 2018 | 6939 | 0.180 |
Why?
|
Cell Shape | 2 | 2023 | 375 | 0.180 |
Why?
|
Oncogene Fusion | 1 | 2020 | 99 | 0.180 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2016 | 2649 | 0.180 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2021 | 134 | 0.170 |
Why?
|
Hematologic Diseases | 1 | 2023 | 498 | 0.170 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13102 | 0.170 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2018 | 417 | 0.170 |
Why?
|
Cathepsins | 1 | 2020 | 241 | 0.170 |
Why?
|
Sarcoma | 2 | 2021 | 1897 | 0.170 |
Why?
|
Hematologic Neoplasms | 2 | 2022 | 1832 | 0.170 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 381 | 0.160 |
Why?
|
Humans | 49 | 2023 | 744343 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2023 | 8949 | 0.160 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 342 | 0.160 |
Why?
|
Duodenal Neoplasms | 1 | 2018 | 106 | 0.160 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2021 | 659 | 0.160 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 44 | 0.160 |
Why?
|
Orotate Phosphoribosyltransferase | 1 | 2017 | 5 | 0.150 |
Why?
|
Orotidine-5'-Phosphate Decarboxylase | 1 | 2017 | 9 | 0.150 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 294 | 0.150 |
Why?
|
Exophthalmos | 1 | 2018 | 97 | 0.150 |
Why?
|
Immunohistochemistry | 5 | 2018 | 11366 | 0.150 |
Why?
|
Antigen Presentation | 2 | 2020 | 1284 | 0.150 |
Why?
|
Skull Neoplasms | 1 | 2018 | 173 | 0.150 |
Why?
|
Sphenoid Bone | 1 | 2018 | 172 | 0.150 |
Why?
|
Middle Aged | 22 | 2021 | 213383 | 0.150 |
Why?
|
Mutation, Missense | 2 | 2018 | 2564 | 0.150 |
Why?
|
Genes, Tumor Suppressor | 2 | 2021 | 1097 | 0.140 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 927 | 0.140 |
Why?
|
Cell Proliferation | 1 | 2012 | 10481 | 0.140 |
Why?
|
rho GTP-Binding Proteins | 1 | 2018 | 293 | 0.140 |
Why?
|
Receptors, IgG | 1 | 2019 | 582 | 0.140 |
Why?
|
Thiophenes | 1 | 2020 | 588 | 0.140 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 670 | 0.130 |
Why?
|
Hydronephrosis | 1 | 2017 | 269 | 0.130 |
Why?
|
Chromosome Aberrations | 3 | 2018 | 1813 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 380 | 0.130 |
Why?
|
HIV Infections | 2 | 2020 | 16718 | 0.130 |
Why?
|
Chromosomes, Human | 1 | 2017 | 457 | 0.130 |
Why?
|
Genomics | 3 | 2021 | 5720 | 0.130 |
Why?
|
Thymus Hyperplasia | 1 | 2014 | 30 | 0.130 |
Why?
|
Culture Media | 1 | 2017 | 908 | 0.130 |
Why?
|
Neovascularization, Physiologic | 1 | 2002 | 1351 | 0.130 |
Why?
|
Thymectomy | 1 | 2014 | 191 | 0.120 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2013 | 35 | 0.120 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2018 | 571 | 0.120 |
Why?
|
Tomography, X-Ray | 1 | 2013 | 61 | 0.120 |
Why?
|
Male | 24 | 2021 | 350118 | 0.120 |
Why?
|
Refractometry | 1 | 2013 | 56 | 0.120 |
Why?
|
Splenectomy | 1 | 2015 | 395 | 0.120 |
Why?
|
Leukemia, B-Cell | 1 | 2013 | 86 | 0.110 |
Why?
|
Multienzyme Complexes | 1 | 2017 | 686 | 0.110 |
Why?
|
Receptors, Immunologic | 1 | 2019 | 1423 | 0.110 |
Why?
|
Smoking | 1 | 2010 | 8987 | 0.110 |
Why?
|
I-kappa B Kinase | 1 | 2014 | 252 | 0.110 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2020 | 3523 | 0.110 |
Why?
|
Back Pain | 1 | 2017 | 545 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5442 | 0.110 |
Why?
|
B-Lymphocytes | 2 | 2023 | 4665 | 0.110 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2018 | 986 | 0.110 |
Why?
|
Autopsy | 1 | 2016 | 1020 | 0.100 |
Why?
|
Reed-Sternberg Cells | 1 | 2012 | 73 | 0.100 |
Why?
|
Female | 23 | 2021 | 380194 | 0.100 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57776 | 0.100 |
Why?
|
Aged | 16 | 2021 | 163280 | 0.100 |
Why?
|
Face | 1 | 2018 | 994 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2021 | 2948 | 0.100 |
Why?
|
Lung | 1 | 2010 | 9856 | 0.100 |
Why?
|
Immunoglobulin Light Chains | 1 | 2012 | 277 | 0.100 |
Why?
|
Uric Acid | 1 | 2017 | 766 | 0.100 |
Why?
|
Pyrimidines | 2 | 2020 | 2942 | 0.100 |
Why?
|
Sulfonamides | 1 | 2020 | 1938 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2020 | 3586 | 0.090 |
Why?
|
Radiography | 2 | 2013 | 7023 | 0.090 |
Why?
|
Prognosis | 4 | 2023 | 29063 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8428 | 0.090 |
Why?
|
Soft Tissue Neoplasms | 1 | 2020 | 1363 | 0.090 |
Why?
|
Specimen Handling | 1 | 2015 | 694 | 0.090 |
Why?
|
Fever | 1 | 2018 | 1616 | 0.090 |
Why?
|
Ki-67 Antigen | 1 | 2012 | 644 | 0.090 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10180 | 0.090 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4456 | 0.090 |
Why?
|
NF-kappa B | 2 | 2018 | 2499 | 0.090 |
Why?
|
Body Height | 1 | 2016 | 1577 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2020 | 4554 | 0.090 |
Why?
|
Eye | 1 | 2013 | 729 | 0.090 |
Why?
|
Adult | 13 | 2021 | 214055 | 0.080 |
Why?
|
Spleen | 1 | 2015 | 2362 | 0.080 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2012 | 627 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3920 | 0.080 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2009 | 75 | 0.080 |
Why?
|
Necrosis | 1 | 2012 | 1643 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 1941 | 0.080 |
Why?
|
Mitochondria | 1 | 2020 | 3520 | 0.080 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2009 | 426 | 0.070 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1041 | 0.070 |
Why?
|
Cough | 1 | 2010 | 555 | 0.070 |
Why?
|
Pain | 2 | 2013 | 4986 | 0.070 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1184 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5535 | 0.070 |
Why?
|
Signal Transduction | 6 | 2020 | 23403 | 0.070 |
Why?
|
Infant | 4 | 2018 | 35136 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4409 | 0.070 |
Why?
|
Neurons | 2 | 2002 | 9338 | 0.070 |
Why?
|
Lymphocyte Activation | 2 | 2018 | 5524 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5172 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2018 | 20129 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2529 | 0.070 |
Why?
|
Nuclear Proteins | 2 | 2018 | 5853 | 0.070 |
Why?
|
Child | 6 | 2021 | 77709 | 0.070 |
Why?
|
Crohn Disease | 1 | 2018 | 2303 | 0.060 |
Why?
|
Body Weight | 1 | 2016 | 4669 | 0.060 |
Why?
|
Antigens, CD | 2 | 2013 | 4026 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1061 | 0.060 |
Why?
|
Young Adult | 6 | 2020 | 56430 | 0.060 |
Why?
|
Lymphocytes | 1 | 2012 | 2617 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2013 | 2107 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3647 | 0.060 |
Why?
|
Reproducibility of Results | 5 | 2023 | 19905 | 0.050 |
Why?
|
Myocardium | 1 | 2016 | 4776 | 0.050 |
Why?
|
Co-Repressor Proteins | 1 | 2023 | 194 | 0.050 |
Why?
|
Mice | 8 | 2023 | 81183 | 0.050 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2009 | 810 | 0.050 |
Why?
|
Survival Rate | 2 | 2018 | 12788 | 0.050 |
Why?
|
Myelodysplastic Syndromes | 1 | 2012 | 1352 | 0.050 |
Why?
|
Child, Preschool | 2 | 2016 | 41006 | 0.050 |
Why?
|
Plaque, Atherosclerotic | 1 | 2013 | 1519 | 0.050 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 1791 | 0.050 |
Why?
|
Adolescent | 5 | 2019 | 85781 | 0.050 |
Why?
|
Receptors, Growth Factor | 1 | 2002 | 334 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9438 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2018 | 9648 | 0.050 |
Why?
|
Animals | 10 | 2023 | 168757 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 772 | 0.050 |
Why?
|
Epithelioid Cells | 1 | 2020 | 71 | 0.040 |
Why?
|
Algorithms | 2 | 2018 | 13881 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 694 | 0.040 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2020 | 318 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9239 | 0.040 |
Why?
|
Antigens, CD1d | 1 | 2020 | 220 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18370 | 0.040 |
Why?
|
Lymphokines | 1 | 2002 | 949 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 664 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10638 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 724 | 0.040 |
Why?
|
Brain | 2 | 2002 | 26385 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2002 | 604 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2010 | 2071 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 94 | 0.040 |
Why?
|
Skin | 2 | 2022 | 4364 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2021 | 19229 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4186 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1783 | 0.040 |
Why?
|
Cohort Studies | 3 | 2019 | 40561 | 0.040 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 217 | 0.040 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2018 | 241 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 940 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2009 | 1671 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2018 | 326 | 0.040 |
Why?
|
Forensic Pathology | 1 | 2016 | 27 | 0.040 |
Why?
|
Automation, Laboratory | 1 | 2017 | 101 | 0.040 |
Why?
|
World Health Organization | 1 | 2022 | 1318 | 0.030 |
Why?
|
Entropy | 1 | 2017 | 209 | 0.030 |
Why?
|
Postmortem Changes | 1 | 2016 | 126 | 0.030 |
Why?
|
Length of Stay | 1 | 2009 | 6309 | 0.030 |
Why?
|
Receptors, Fc | 1 | 2019 | 541 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 688 | 0.030 |
Why?
|
Disease Progression | 1 | 2012 | 13284 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2020 | 635 | 0.030 |
Why?
|
Cell Separation | 1 | 2001 | 1751 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1475 | 0.030 |
Why?
|
Estrogens | 1 | 2002 | 1566 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 528 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13695 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2017 | 684 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9727 | 0.030 |
Why?
|
Immune Evasion | 1 | 2018 | 360 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5181 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4568 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2002 | 1660 | 0.030 |
Why?
|
Cytokines | 2 | 2020 | 7322 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1677 | 0.030 |
Why?
|
Epitopes | 1 | 2020 | 2571 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16365 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2023 | 2849 | 0.030 |
Why?
|
Serum Albumin | 1 | 2016 | 676 | 0.030 |
Why?
|
X-Rays | 1 | 2013 | 301 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1375 | 0.030 |
Why?
|
Benchmarking | 1 | 2019 | 1042 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1785 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2386 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2017 | 1100 | 0.030 |
Why?
|
Fluorouracil | 1 | 2017 | 1619 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2012 | 25625 | 0.030 |
Why?
|
Dermis | 1 | 2013 | 207 | 0.030 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2012 | 322 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 16689 | 0.030 |
Why?
|
Testosterone | 1 | 2002 | 2420 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2012 | 403 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 3508 | 0.020 |
Why?
|
Melphalan | 1 | 2012 | 431 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 432 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2252 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4204 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1094 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2009 | 7659 | 0.020 |
Why?
|
Cell Movement | 1 | 2002 | 5217 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2018 | 2480 | 0.020 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 491 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2001 | 5867 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2013 | 1950 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1678 | 0.020 |
Why?
|
Gene Deletion | 1 | 2017 | 2751 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2021 | 3386 | 0.020 |
Why?
|
Dogs | 1 | 2013 | 3912 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1405 | 0.020 |
Why?
|
Urban Health Services | 1 | 2009 | 179 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14722 | 0.020 |
Why?
|
Stem Cells | 1 | 2001 | 3567 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5974 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5097 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3128 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 13815 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11524 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2012 | 810 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2009 | 440 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2009 | 499 | 0.020 |
Why?
|
Thoracotomy | 1 | 2009 | 363 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2012 | 2242 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4420 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3588 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3462 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2133 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2013 | 20822 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7722 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9386 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9734 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2014 | 77449 | 0.020 |
Why?
|
Glucose | 1 | 2017 | 4397 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18029 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39050 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7799 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8324 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12208 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9583 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
Mammography | 1 | 2013 | 2476 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2009 | 1094 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6489 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8663 | 0.010 |
Why?
|
Patient Admission | 1 | 2009 | 1380 | 0.010 |
Why?
|
Urban Population | 1 | 2009 | 2021 | 0.010 |
Why?
|
Tissue Transplantation | 1 | 2001 | 130 | 0.010 |
Why?
|
Point-of-Care Systems | 1 | 2009 | 1177 | 0.010 |
Why?
|
Intermediate Filament Proteins | 1 | 2001 | 269 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2759 | 0.010 |
Why?
|
Retroviridae | 1 | 2001 | 914 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2001 | 853 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7729 | 0.010 |
Why?
|
Adenoviridae | 1 | 2001 | 1099 | 0.010 |
Why?
|
Neuroglia | 1 | 2001 | 927 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2088 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17446 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3846 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 2699 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2001 | 1903 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 35421 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4462 | 0.010 |
Why?
|
Time Factors | 1 | 2009 | 40075 | 0.000 |
Why?
|